MASLD in Children: Integrating Epidemiological Trends with Mechanistic and Translational Advances

By integrating epidemiological trends, mechanistic insights, and translational advances, scientists highlight opportunities for targeted therapies and prevention strategies aimed at mitigating early-life drivers of metabolic dysfunction–associated steatotic liver disease.